Zobrazeno 1 - 10
of 68
pro vyhledávání: '"Daniel Sommermeyer"'
Autor:
Daniel Sommermeyer, Chloé Beuraud, Monika Braun, Michael Epstein, Philip Hublitz, Michael Esquerré, Audrey Holtzinger, Nadja Wagner, Riga Tawo, Florie Bertrand, Olivia Cypris, Pauline Barron, Stefanie Pfänder, Stephanie Sontag
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/1b6c6dd10de94ead9a4f07c09f966c27
Autor:
Daniel Sommermeyer, Monika Braun, Michael Epstein, Tanja Schneider, Kathrin Haake, Michela Mirenda, Quentin Bernard, Philip Hublitz, Lucie Gouxette, Martin Briscadieu, Philine Scheinpflug, Garima Singh, Alica Hinkelmann, Michael Esquerré, Audrey Holtzinger, Michael Paillasse, Andreas Scheel, Markus Dangl, Nadja Wagner
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 2 (2023)
Externí odkaz:
https://doaj.org/article/32c01a21801d4da69a13e33bcf0b7918
Autor:
Daniel Sommermeyer, Christian Ellinger, Giulia Longinotti, Dolores J Schendel, Michael S Magee, Kathrin Davari, Tristan Holland, Laura Prassmayer, Iulia Diaconu, Kenneth P Ganley, Lisa J Pechilis, Prashant R Nambiar
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 3 (2021)
Background The cancer-testis antigen MAGE-A4 is an attractive target for T-cell-based immunotherapy, especially for indications with unmet clinical need like non-small cell lung or triple-negative breast cancer.Methods An unbiased CD137-based sorting
Externí odkaz:
https://doaj.org/article/6790f2555dec4bc39ad9b227b670bd0f
Autor:
Elfriede Noessner, Daniel Sommermeyer, Christian Ellinger, Nadja Sailer, Melanie Salvermoser, Maria Gerget, Franziska Hasselmann, Monika Braun
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/51636d5c499d4f79be0bd958b356b0af
Autor:
Daniel Sommermeyer, Christian Ellinger, Giulia Longinotti, Dolores Schendel, Kathrin Davari, Tristan Holland, Laura Prassmayer, Kenneth Ganley, Lisa Pechilis, Iulia Diaconu, Prashant Nambiar, Mike Magee, Rer Nat
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/11d88044b9c6474b92feb1ab839e3027
Autor:
Stanley R. Riddell, Christoph Rader, Paula L. Kosasih, Paulina J. Paszkiewicz, Ashwini Balakrishnan, Michael Berger, Michael Hudecek, Daniel Sommermeyer, Carolina Berger
Serum chemistry and cytokine levels in control animals.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::34d9014dac1312d7cebb9a7c6e0e2ae1
https://doi.org/10.1158/2326-6066.22537684.v1
https://doi.org/10.1158/2326-6066.22537684.v1
Autor:
Stanley R. Riddell, Michael C. Jensen, Christoph Rader, Lingfeng Liu, Anne Silva-Benedict, Paula L. Kosasih, Daniel Sommermeyer, Michael Hudecek
10 million (A) CD8+ TCM-derived CD19-CAR-T-cells, (B) CD19-CAR-T-cells derived from an unselected T-cell population, or (C) CD8+ TCM-derived ROR1-CAR-T-cells were injected into tumor-free NSG mice. After 24 hours, bone marrow, spleens, and peripheral
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ae10c6e8a10973bae238bca692270f8
https://doi.org/10.1158/2326-6066.22537916
https://doi.org/10.1158/2326-6066.22537916
Autor:
Stanley R. Riddell, Michael C. Jensen, Christoph Rader, Lingfeng Liu, Anne Silva-Benedict, Paula L. Kosasih, Daniel Sommermeyer, Michael Hudecek
(A) Cytolytic activity of CD8+ TCM-derived T-cells expressing long/CD28, long/4-1BB, and long/CD28_4-1BB CD19-CARs against K562/CD19, K562, and Raji cells. (B) Cytokine production by CAR-T-cells after co-culturing with Raji cells. Supernatants were o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c94a9aaaa94797ba021685d275ae158
https://doi.org/10.1158/2326-6066.22537922.v1
https://doi.org/10.1158/2326-6066.22537922.v1
Autor:
Stanley R. Riddell, Christoph Rader, Paula L. Kosasih, Paulina J. Paszkiewicz, Ashwini Balakrishnan, Michael Berger, Michael Hudecek, Daniel Sommermeyer, Carolina Berger
Genetic engineering of T cells for adoptive transfer by introducing a tumor-targeting chimeric antigen receptor (CAR) is a new approach to cancer immunotherapy. A challenge for the field is to define cell surface molecules that are both preferentiall
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eaf7d3721068d2fec44afb4780d2f1d3
https://doi.org/10.1158/2326-6066.c.6548518.v1
https://doi.org/10.1158/2326-6066.c.6548518.v1
Autor:
Stanley R. Riddell, Michael C. Jensen, Christoph Rader, Lingfeng Liu, Anne Silva-Benedict, Paula L. Kosasih, Daniel Sommermeyer, Michael Hudecek
The use of synthetic chimeric antigen receptors (CAR) to redirect T cells to recognize tumor provides a powerful new approach to cancer immunotherapy; however, the attributes of CARs that ensure optimal in vivo tumor recognition remain to be defined.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0180856ac7c41ad413d3a4d3ad4e801c
https://doi.org/10.1158/2326-6066.c.6548606.v1
https://doi.org/10.1158/2326-6066.c.6548606.v1